The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
Marta TonelloAntonia CalligaroMaria FavaroTeresa Del RossPaola VeroneseElisa SalvanMaria Teresa GervasiAmelia RuffattiPublished in: Archives of gynecology and obstetrics (2020)
Just as for aPL carriers, closer monitoring and possibly, a pharmacological prophylaxis should be reserved for OAPS patients at highest risk of developing the first thrombotic event.